BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24188815)

  • 21. Imaging beta amyloid aggregation and iron accumulation in Alzheimer's disease using quantitative susceptibility mapping MRI.
    Gong NJ; Dibb R; Bulk M; van der Weerd L; Liu C
    Neuroimage; 2019 May; 191():176-185. PubMed ID: 30739060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
    Poduslo JF; Wengenack TM; Curran GL; Wisniewski T; Sigurdsson EM; Macura SI; Borowski BJ; Jack CR
    Neurobiol Dis; 2002 Nov; 11(2):315-29. PubMed ID: 12505424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease.
    Dhenain M; Delatour B; Walczak C; Volk A
    Magn Reson Med; 2006 Mar; 55(3):687-93. PubMed ID: 16470593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The comparative study on high field MRI and pathology of Alzheimer's disease transgenic mice].
    Li MH; Wang PJ; Chen SQ; Zhang W; Gao XL
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(13):876-9. PubMed ID: 21600112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
    Duffy AM; Hölscher C
    Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative evaluation of MRI and histological characteristics of the 5xFAD Alzheimer mouse brain.
    Spencer NG; Bridges LR; Elderfield K; Amir K; Austen B; Howe FA
    Neuroimage; 2013 Aug; 76():108-15. PubMed ID: 23507393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain Amyloidosis and BDNF Deficiency Have Opposite Effects on Brain Volumes in AβPP/PS1 Mice Both in vivo and ex vivo.
    Kärkkäinen E; Lahtinen HM; Närväinen J; Gröhn O; Tanila H
    J Alzheimers Dis; 2015; 46(4):929-46. PubMed ID: 26402627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
    Wadghiri YZ; Li J; Wang J; Hoang DM; Sun Y; Xu H; Tsui W; Li Y; Boutajangout A; Wang A; de Leon M; Wisniewski T
    PLoS One; 2013; 8(2):e57097. PubMed ID: 23468919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detecting amyloid-β plaques in Alzheimer's disease.
    Baltes C; Princz-Kranz F; Rudin M; Mueggler T
    Methods Mol Biol; 2011; 711():511-33. PubMed ID: 21279620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
    Yang J; Wadghiri YZ; Hoang DM; Tsui W; Sun Y; Chung E; Li Y; Wang A; de Leon M; Wisniewski T
    Neuroimage; 2011 Apr; 55(4):1600-9. PubMed ID: 21255656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
    Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy.
    Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR
    Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of Alzheimer's disease (AβPP/PS1).
    Esteras N; Alquézar C; Bartolomé F; Antequera D; Barrios L; Carro E; Cerdán S; Martín-Requero A
    J Alzheimers Dis; 2012; 30(2):337-53. PubMed ID: 22406445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal or glial expression of human apolipoprotein e4 affects parenchymal and vascular amyloid pathology differentially in different brain regions of double- and triple-transgenic mice.
    Van Dooren T; Muyllaert D; Borghgraef P; Cresens A; Devijver H; Van der Auwera I; Wera S; Dewachter I; Van Leuven F
    Am J Pathol; 2006 Jan; 168(1):245-60. PubMed ID: 16400027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered brain development in an early-onset murine model of Alzheimer's disease.
    Allemang-Grand R; Scholz J; Ellegood J; Cahill LS; Laliberté C; Fraser PE; Josselyn SA; Sled JG; Lerch JP
    Neurobiol Aging; 2015 Feb; 36(2):638-47. PubMed ID: 25311279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inositol trisphosphate 3-kinase B is increased in human Alzheimer brain and exacerbates mouse Alzheimer pathology.
    Stygelbout V; Leroy K; Pouillon V; Ando K; D'Amico E; Jia Y; Luo HR; Duyckaerts C; Erneux C; Schurmans S; Brion JP
    Brain; 2014 Feb; 137(Pt 2):537-52. PubMed ID: 24401760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.